Genetic Acute Necrotizing Encephalopathy Associated with RANBP2: Clinical and Therapeutic Implications in Pediatrics
- 1 August 2020
- journal article
- review article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 43, 102194
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Cellular and Molecular Life Sciences, 2012
- Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stressDisease Models & Mechanisms, 2010
- Acute Necrotizing Encephalopathy in 3 BrothersPediatrics, 2010
- Clinical Spectrum and Prognostic Factors of Acute Necrotizing Encephalopathy in ChildrenJournal of Korean Medical Science, 2010
- Delirious behavior in children with acute necrotizing encephalopathyBrain and Development, 2009
- Outcome of acute necrotizing encephalopathy in relation to treatment with corticosteroids and gammaglobulinBrain and Development, 2009
- Infection-Triggered Familial or Recurrent Cases of Acute Necrotizing Encephalopathy Caused by Mutations in a Component of the Nuclear Pore, RANBP2The American Journal of Human Genetics, 2009
- RanBP2 Modulates Cox11 and Hexokinase I Activities and Haploinsufficiency of RanBP2 Causes Deficits in Glucose MetabolismPLOS Genetics, 2006
- Acute Necrotizing Encephalopathy Associated With Hemophagocytic SyndromePediatric Neurology, 2006
- Serial neuroimages of acute necrotizing encephalopathy associated with human herpesvirus 6 infectionBrain and Development, 1995